Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
56.63
+1.21 (2.18%)
Aug 12, 2026, 11:07 AM EDT - Market open
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Ionis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $89.33. The average 1-year stock price forecast is 57.74% higher than the current stock price, while the lowest is $66 (+16.55%) and the highest is $115 (+103.07%).
Price Target: $89.33 (+57.74%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 12 | 12 | 10 | 10 |
| Buy | 6 | 8 | 9 | 8 | 9 | 9 |
| Hold | 6 | 5 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 24 | 26 | 24 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $76 | Buy | Maintains | $76 | +34.20% | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $115 | Buy | Reiterates | $115 | +103.07% | Aug 5, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $86 → $68 | Hold | Maintains | $86 → $68 | +20.08% | Aug 2, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $94 | Buy | Maintains | $94 | +65.99% | Jul 30, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $85 | Buy | Reiterates | $85 | +50.10% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
920.76M
from 943.71M
Decreased by -2.43%
Revenue Next Year
1.40B
from 920.76M
Increased by 52.21%
EPS This Year
-2.60
from -1.54
EPS Next Year
-1.16
from -2.60
EPS and Forward PE are based on non-GAAP adjusted numbers.